Screening for gene mutations: will identification of NT5C2 mutations help predict the chance of relapse in acute lymphoblastic leukemia?

about

Genomics in acute lymphoblastic leukaemia: insights and treatment implications.

P2860

Q38381463-0790F167-3E52-4A87-BD21-50A674FD0811

P2860

Screening for gene mutations: will identification of NT5C2 mutations help predict the chance of relapse in acute lymphoblastic leukemia?

Item

http://www.wikidata.org/entity/Q41976584

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Screening for gene mutations: ...... acute lymphoblastic leukemia?

@en

type

Item

label

Screening for gene mutations: ...... acute lymphoblastic leukemia?

@en

prefLabel

Screening for gene mutations: ...... acute lymphoblastic leukemia?

@en

P1476

Screening for gene mutations: ...... acute lymphoblastic leukemia?

@en

P2093

Julia A Meyer

http://www.w3.org/2001/XMLSchema#string

Teena Bhatla

http://www.w3.org/2001/XMLSchema#string

William L Carroll

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and characterization of inhibitors of cytoplasmic 5'-nucleotidase cN-II issued from virtual screening

Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL.

High Km soluble 5'-nucleotidase from human placenta. Properties and allosteric regulation by IMP and ATP

Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies.

Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group.

Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia.

Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia.

Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria--a population-based report of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group.

Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia

Outcome after first relapse in childhood acute lymphoblastic leukaemia - lessons from the United Kingdom R2 trial.

P304

223-224

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1586/EHM.13.28

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23782074

http://www.w3.org/2001/XMLSchema#string

P932

4117397

http://www.w3.org/2001/XMLSchema#string

Screening for gene mutations: will identification of NT5C2 mutations help predict the chance of relapse in acute lymphoblastic leukemia?

about

P2860

P2860

Screening for gene mutations: will identification of NT5C2 mutations help predict the chance of relapse in acute lymphoblastic leukemia?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932